Chan Gyoo Kim
Overview
Explore the profile of Chan Gyoo Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
2766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim S, Kim C
Clin Endosc
. 2024 Feb;
57(5):571-580.
PMID: 38389304
Malignant gastric outlet obstruction (GOO) is a condition characterized by blockage or narrowing where the stomach empties its contents into the small intestine due to primary malignant tumors or metastatic...
2.
Kim C
J Gastric Cancer
. 2024 Jan;
24(1):122-134.
PMID: 38225771
Most gastric subepithelial tumors (SETs) are asymptomatic and are often incidentally discovered during endoscopic procedures conducted for unrelated reasons. Although surveillance is sufficient for the majority of gastric SETs, certain...
3.
Park J, Kim T, Cho K, Kim J, Cho J, Jeon J, et al.
Gut Liver
. 2023 Nov;
18(1):77-84.
PMID: 38013476
Background/aims: : This study aimed to review the indications, methods, cooperation, complications, and outcomes of percutaneous endoscopic gastrostomy (PEG). Methods: : Questionnaires were sent to 200 hospitals, of which 62...
4.
Lee J, Oh J, Kim Y, Lee J, Kim C, Choi I, et al.
Medicine (Baltimore)
. 2022 Dec;
101(50):e32085.
PMID: 36550814
Gastric papillary adenocarcinoma is considered a differentiated adenocarcinoma in the current endoscopic submucosal dissection indication guidelines. However, the safety of endoscopic submucosal dissection remains controversial. Currently, data regarding which papillary...
5.
Eom S, Choi W, Eom B, Park S, Kim S, Kim Y, et al.
J Gastric Cancer
. 2022 Apr;
22(1):3-23.
PMID: 35425651
Countries differ in their treatment expertise and research results regarding gastric cancer; hence, treatment guidelines are diverse based on evidence and medical situations. A comprehensive and comparative review of each...
6.
Lee Y, Lee E, Lee Y, Eom B, Yoon H, Kim Y, et al.
J Clin Med
. 2021 Sep;
10(17).
PMID: 34501456
We evaluated the metabolic effects of gastrectomies and endoscopic submucosal dissections (ESDs) in early gastric cancer (EGC) patients with type 2 diabetes mellitus (T2DM). Forty-one EGC patients with T2DM undergoing...
7.
Kim Y, Kim C, Lee J, Choi I, Eom B, Yoon H, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359620
A thread-fix stent entails long hospitalization and patient discomfort. We aimed to evaluate the efficacy of a novel stent with silicone-covered outer double layers without external fixation (Beta stent) for...
8.
Kim Y, Lee J, Khalayleh H, Kim C, Yoon H, Kim S, et al.
Surg Endosc
. 2021 Jul;
36(5):2896-2905.
PMID: 34254185
Background: Anastomotic leakage (AL) after gastrectomy in gastric cancer patients is associated with high mortality rates. Various endoscopic procedures are available to manage this postoperative complication. The aim of study...
9.
Kim S, Eom B, Yoon H, Kim C, Kook M, Kim Y, et al.
Chin J Cancer Res
. 2021 Jun;
33(2):142-149.
PMID: 34158734
With the increase in the incidence of early gastric cancer (EGC), several endoscopic and laparoscopic approaches, such as endoscopic submucosal dissection and function-preserving gastrectomy, have been accepted as standard treatments....
10.
Oh Y, Kim D, Han W, Eom B, Kim Y, Yoon H, et al.
Eur J Surg Oncol
. 2021 May;
47(12):3059-3063.
PMID: 33934939
Background: Lymphatic invasion (LI) is a potent risk factor for lymph node metastasis (LNM) in early gastric cancer (EGC) after endoscopic submucosal dissection (ESD). However, there are also other risk...